Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy
- 28 June 2003
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 46 (7) , 961-971
- https://doi.org/10.1007/s00125-003-1121-9
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Hypertension and diabetesCurrent Opinion in Nephrology and Hypertension, 2002
- Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized ratsKidney International, 2001
- Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 ratKidney International, 2000
- Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase in Rats with HypertensionJournal of Cardiovascular Pharmacology, 1995
- A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat Via Radio-telemetryClinical and Experimental Hypertension. Part A: Theory and Practice, 1991
- A New Radioimmunoassay for Human Alpha Atrial Natriuretic Peptide and Its Physiological ValidationJournal of Immunoassay, 1990
- Short and long term effects of antihypertensive therapy in the diabetic ratKidney International, 1989
- Effects of genetic hypertension on diabetic nephropathy in the rat ??? functional and structural characteristicsJournal Of Hypertension, 1988
- LOCALIZATION OF ANGIOTENSIN CONVERTING ENZYME IN RAT FOREBRAIN AND OTHER TISSUES BY IN VITRO AUTORADIOGRAPHY USING 125‐I‐LABELLED MK351AClinical and Experimental Pharmacology and Physiology, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981